XML 92 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Discontinued Operations - Summary of Financial Results for TS Biotechnology and EnviroFlight (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jan. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss on release of cumulative foreign currency translation adjustment   $ (26,957) $ 0 $ 0
Income (loss) from discontinued operations   (66,748) (153,582) (134,219)
Loss on abandonment and disposals of assets, net   4,442 3,071 20,928
Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue   1,294 12,307 9,396
Operating expenses   896 126,885 111,509
Operating income (loss)   398 (114,578) (102,113)
Gain on sale of discontinued operations   672    
Loss on release of cumulative foreign currency translation adjustment   (26,957)    
Other expense, net   (129) (272) (1,757)
Equity in net loss of affiliates   (38) (4,314) (2,622)
Income (loss) before income taxes   (26,054) (119,164) (106,492)
Income tax expense   (2) 3,005 6,103
Income (loss) from discontinued operations   (26,056) (116,159) (100,389)
TS Biotechnology Sale | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue   1,294 12,307 9,396
Operating expenses   896 116,091 111,039
Operating income (loss)   398 (103,784) (101,643)
Gain on sale of discontinued operations   633    
Loss on release of cumulative foreign currency translation adjustment $ (26,957) (26,957)    
Other expense, net   (129) (272) (1,757)
Income (loss) before income taxes   (26,055) (104,056) (103,400)
Income tax expense   (2) 3,005 6,103
Income (loss) from discontinued operations   (26,057) (101,051) (97,297)
EnviroFlight Sale | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue   0 0 0
Operating expenses   0 10,794 470
Operating income (loss)   0 (10,794) (470)
Gain on sale of discontinued operations   39    
Loss on release of cumulative foreign currency translation adjustment   0    
Other expense, net   0 0 0
Equity in net loss of affiliates   (38) (4,314) (2,622)
Income (loss) before income taxes   1 (15,108) (3,092)
Income tax expense   0 0 0
Income (loss) from discontinued operations   1 (15,108) (3,092)
TS Biotechnology Holdings LLC and Enviro Flight LLC | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss on release of cumulative foreign currency translation adjustment   (26,957) 0 0
Impairment charges     89,679  
TS Biotechnology Holdings LLC and Enviro Flight LLC | Discontinued Operations, Disposed of by Sale | Oxitec        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Impairment charges       60,504
Loss on abandonment and disposals of assets, net       5,057
Related Parties, Aggregated | TS Biotechnology Sale | Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue   $ 436 $ 3,042 $ 4,665